News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Obese breast cancer patients on T-DM1 prone to more treatment adjustments
04 Feb 2022
More treatment modifications secondary to adverse events appear necessary among obese patients receiving ado-trastuzumab emtansine (T-DM1), an antibody-drug conjugate indicated for the treatment of HER2-positive breast cancer, relative to nonobese counterparts, reports a study.
04 Feb 2022

Systemic inflammation mediates obesity-related severe COVID-19
04 Feb 2022
byStephen Padilla
Systemic inflammation plays a significant role in severe COVID-19 associated with obesity, particularly in patients aged <65 years, as captured by peak C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR), a study has found.
04 Feb 2022






